LONA insider transactions
LeonaBio Inc. (LONA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
LONA insiders
Everyone who has filed a Form 3, 4, 5 or 144 at LeonaBio Inc., latest first. Follow anyone to get their next filing.
- David J. Portman10% owner, since August 2026
- Perceptive Advisors LLCDirector, 10% owner+$12.6M
- Fred CalloriDirector, since May 2026
- Natalie C. HollesDirector, since May 2026
- Peter B. SilvermanDirector, since May 2026
- Michael A. PanzaraDirector, since March 2022
- Kelly A RomanoDirector+$304K
- Joseph EdelmanDirector
- James A JohnsonDirector+$12K
- Barbara KosaczDirector, since March 2021
- Grant PickeringDirector, since January 2022+$60.4K
- Kevin ChurchChief Scientific Officer-$43.1K
- Martin Javier SanChief Medical Officer, since April 2024-$29.8K
- John M Fluke JrDirector
- Mark WorthingtonGENERAL COUNSEL and CCO, since June 2021-$42.9K
- Robert RenningerChief Financial Officer, since October 2024-$9,378
- Mark James LittonPRESIDENT and CEO, Director-$119K
- Andrew GengosCFO and Chief Business Officer, since May 2023+$243K-$7,751
- Rachel LeningtonCOO and CDO, since June 2021-$26.7K
- Hans MoebiusChief Medical Officer+$45.2K
- Glenna MilesonOfficer+$142K-$7,032
- Leen KawasOfficer, Director
Recent Form 3, 4, and 5 filings for LONA
- Large owner Portman David J. bought $9,919,161,281 worth of shares (3,149,470 units at $3,149.47) (SEC Form 4)4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by LeonaBio Inc.4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 3 filed by new insider Portman David J.3 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Director Perceptive Advisors Llc4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Director Perceptive Advisors Llc4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Director Callori Fred4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Director Holles Natalie C.4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Director Silverman Peter B.4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Director Panzara Michael A.4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Director Romano Kelly A4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Director Edelman Joseph4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Director Johnson James A4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Director Kosacz Barbara4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Director Pickering Grant4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Director Holles Natalie C.4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Director Silverman Peter B.4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Director Callori Fred4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 3 filed by new insider Silverman Peter B.3 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 3 filed by new insider Holles Natalie C.3 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 3 filed by new insider Callori Fred3 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Panzara Michael A.4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Church Kevin4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Kosacz Barbara4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Pickering Grant4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Romano Kelly A4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Johnson James A4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Edelman Joseph4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by San Martin Javier4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Fluke John M Jr4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Worthington Mark4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Renninger Robert4 - LeonaBio, Inc. (0001620463) (Issuer)
- SEC Form 4 filed by Litton Mark James4 - LeonaBio, Inc. (0001620463) (Issuer)
- PRESIDENT and CEO Litton Mark James converted options into 22,254 shares and sold $27,688 worth of shares (5,156 units at $5.37), increasing direct ownership by 42% to 57,926 units (SEC Form 4)4 - LeonaBio, Inc. (0001620463) (Issuer)
- CHIEF FINANCIAL OFFICER Renninger Robert converted options into 3,900 shares and sold $4,865 worth of shares (906 units at $5.37), increasing direct ownership by 23% to 15,851 units (SEC Form 4)4 - LeonaBio, Inc. (0001620463) (Issuer)
- GENERAL COUNSEL and CCO Worthington Mark converted options into 5,726 shares and sold $7,131 worth of shares (1,328 units at $5.37), increasing direct ownership by 31% to 18,376 units (SEC Form 4)4 - LeonaBio, Inc. (0001620463) (Issuer)
- CHIEF SCIENTIFIC OFFICER Church Kevin converted options into 5,856 shares and sold $7,298 worth of shares (1,359 units at $5.37), increasing direct ownership by 22% to 25,178 units (SEC Form 4)4 - LeonaBio, Inc. (0001620463) (Issuer)
- CHIEF MEDICAL OFFICER San Martin Javier converted options into 7,418 shares and sold $9,236 worth of shares (1,720 units at $5.37), increasing direct ownership by 56% to 15,887 units (SEC Form 4)4 - LeonaBio, Inc. (0001620463) (Issuer)